Esperion Therapeutics
ESPR
#6604
Rank
โ‚ฌ0.71 B
Marketcap
2,79ย โ‚ฌ
Share price
0.00%
Change (1 day)
184.36%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of March 2026 : -โ‚ฌ0.27 Billion

According to Esperion Therapeutics's latest financial reports the company has -โ‚ฌ0.27 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-โ‚ฌ0.26 Billion-31.19%
2024-12-31$-โ‚ฌ0.38 Billion-9.24%
2023-12-31$-โ‚ฌ0.42 Billion36.36%
2022-12-31$-โ‚ฌ0.31 Billion73.57%
2021-12-31$-โ‚ฌ0.18 Billion122.5%
2020-12-31$-โ‚ฌ78.16 Million-538.87%
2019-12-31$โ‚ฌ17.8 M-74.25%
2018-12-31$โ‚ฌ69.15 M-66.09%
2017-12-31$โ‚ฌ0.20 B-6.17%
2016-12-31$โ‚ฌ0.21 B-17.28%
2015-12-31$โ‚ฌ0.26 B139.25%
2014-12-31$โ‚ฌ0.10 B104.68%
2013-12-31$โ‚ฌ53.65 M-508.1%
2012-12-31$-โ‚ฌ13.15 Million181.88%
2011-12-31$-โ‚ฌ4.67 Million
2002-12-31$โ‚ฌ37.06 M-50.78%
2001-12-31$โ‚ฌ75.29 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
โ‚ฌ79.19 B-29,458.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ27.52 B-10,304.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.21 Billion-25.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ0.17 B-165.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.24 B-189.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ5.44 B-2,117.37%๐Ÿ‡บ๐Ÿ‡ธ USA